AIML Announces Proposed Private Placement
VANCOUVER, BC / ACCESS Newswire / September 4, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased...
Healthcare
Ensysce Biosciences Showcases Urgent Need for Safer Opioids at PAINWeek 2025 Symposium
~ Experts Spotlight TAAP™ and MPAR® as Next-Generation Solutions for Severe Pain ~ SAN DIEGO, CA / ACCESS Newswire /...
Predictive Oncology and Every Cure Announce a Strategic Collaboration to Pursue Drug Repurposing for Cancer Patients
Collaboration builds upon positive results utilizing Predictive Oncology’s AI platform to identify new indications for existing drugsPITTSBURGH, Sept. 04, 2025...
SCYNEXIS Announces Multiple Presentations Highlighting Data from its Second-Generation Fungerp, SCY-247, at the 12th Congress on Trends in Medical Mycology (TIMM-12)
Oral presentation will feature data demonstrating SCY-247 in vitro activity against C. auris strains, including isolates with mutations commonly associated...
Vivani Medical Provides Update on Clinical Development Plans for NPM-139 Semaglutide Implant for Chronic Weight Management
NPM-139 has potential to provide Wegovy®-level efficacy with once or twice-yearly administration First-in-human Phase 1 study is expected to initiate...
IO Biotech Announces Participation in Upcoming Investor Conferences
NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf...
Sangamo Therapeutics Presents Detailed Data from Registrational STAAR Study in Fabry Disease at International Congress of Inborn Errors of Metabolism 2025
Totality of data supports potential for isaralgagene civaparvovec as a one-time, durable treatment of the underlying pathology of Fabry disease...
Connect Biopharma Announces Two Presentations at the European Respiratory Society (ERS) Congress 2025
SAN DIEGO, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma, Connect or the Company),...
Beacon Therapeutics Announces Positive Interim 9+ Month Results from DAWN Trial and 36-Month Phase 2 SKYLINE Trial Data for Laru-zova in Patients with X-linked Retinitis Pigmentosa (XLRP) at EURETINA 2025
Data showed sustained improvements across several key measures of visual function, including low luminance visual acuity and microperimetry Laru-zova was...
Alignment Health Earns Spot on Newsweek’s World’s Most Trustworthy Companies 2025 List for Third Consecutive Year
Global recognition highlights the company’s leadership in quality, member satisfaction and long-term growthORANGE, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) --...
Cidara Therapeutics to Participate in September Investor Conferences
SAN DIEGO, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak®...
Elutia Selected to Exhibit EluPro™ Antibiotic Eluting BioEnvelope at Vizient Innovative Technology Exchange
GAITHERSBURG, Md., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting...
Sectra’s three-month interim report 2025/2026: Order bookings doubled following success in the US and Canada
LINKÖPING, Sweden, Sept. 4, 2025 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) reports double order bookings,...
Military Veterans Join Virtue Recovery to Expand Community Outreach With Hope and Support
Virtue Recovery has expanded its Business Development Team with the addition of two American Veterans, Adam Khosroabadi and Chauncy Nash....
DEA Marijuana Decision Showtime: MMJ Issues Demand Letter on DEA
Duane Boise stated "In a September 3rd letter to DEA Terry Cole, that the Administrative Procedure Act requires agencies to...
FoW Partners Launches Elevated Veterinary Solutions with Industry Leader Torie Madore
PORTLAND, Maine, Sept. 3, 2025 /PRNewswire/ -- FoW Partners, an investment firm focused on building great companies through workforce-centric strategies...
Remedy Meds to Acquire Thirty Madison, Expanding Telehealth Capabilities Across Men’s, Women’s, and Metabolic Health
Combination pairs leading brands: Remedy Meds, Keeps, Nurx, and Cove, with a nationwide clinician and pharmacy network to expand access...
PsychNow Unveils Fillm™: A First-of-Its-Kind Feature That Brings Patients’ Personal AI Into Behavioral Healthcare
CHICAGO, Sept. 3, 2025 /PRNewswire/ -- PsychNow today announced Fillm™, a patent-pending feature that for the first time allows patients to...
BookJane Unveils Automated Scheduling Intelligence: The Future of Workforce Management
BookJane Launches Automated Scheduling Intelligence: A Game-Changer for Workforce Management in Healthcare and Beyond TORONTO, ON / ACCESS Newswire /...
Prominence Advisors Acquires Tegra Analytics, Marking Entry into Life Sciences
The Partnership Brings Together Healthcare and Life Sciences Expertise to Drive Data Enablement Innovation CHICAGO, Sept. 3, 2025 /PRNewswire/ --...